These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15023718)

  • 21. Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):719-28. PubMed ID: 23750681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New drug combo lowers blood pressure: all diabetics benefit. Two drugs offer lifesaving benefits, even in diabetes with normal blood pressure.
    Duke Med Health News; 2007 Dec; 13(12):1, 11. PubMed ID: 18286728
    [No Abstract]   [Full Text] [Related]  

  • 23. Renoprotection with antihypertensive agents.
    Fournier A; Presne C; Makdassi R; Mazouz H; Choukroun G
    Lancet; 2002 May; 359(9318):1694-5. PubMed ID: 12020553
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of hypertension in patients with diabetes mellitus.
    Agarwal R
    Indian Heart J; 2001; 53(3):361-9. PubMed ID: 11516043
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of hypertension in the progression of diabetic microangiopathy].
    Kamide K; Rakugi H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():98-102. PubMed ID: 15999692
    [No Abstract]   [Full Text] [Related]  

  • 27. [Which antihypertensive therapy is indicated in type 2 diabetic patients?].
    Hauner H
    Dtsch Med Wochenschr; 2002 Jul; 127(28-29):1543-4. PubMed ID: 12111665
    [No Abstract]   [Full Text] [Related]  

  • 28. [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].
    Wolffenbuttel BH; Heine RJ
    Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1197-201. PubMed ID: 10389533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of chemical therapies for treating diabetic hypertension.
    Sarafidis PA; Alexandrou ME; Ruilope LM
    Expert Opin Pharmacother; 2017 Jun; 18(9):909-923. PubMed ID: 28480805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertension in type II diabetes mellitus].
    Irsigler K
    Acta Med Austriaca; 1991; 18(3):57-60. PubMed ID: 1950378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of antihypertensive therapy in decreasing renal and cardiovascular complications in diabetes mellitus.
    Nosadini R; Abaterusso C; Dalla Vestra M; Bortoloso E; Saller A; Bruseghin M; Sfriso A; Trevisan M
    Nephrol Dial Transplant; 1998; 13 Suppl 8():44-8. PubMed ID: 9870425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
    Pahor M; Psaty BM; Alderman MH; Applegate WB; Williamson JD; Furberg CD
    Diabetes Care; 2000 Jul; 23(7):888-92. PubMed ID: 10895836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J).
    Kawamori R; Daida H; Tanaka Y; Miyauchi K; Kitagawa A; Hayashi D; Kishimoto J; Ikeda S; Imai Y; Yamazaki T
    BMC Cardiovasc Disord; 2006 Oct; 6():39. PubMed ID: 17029631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADVANCE: blood pressure lowering in diabetes.
    Patel A; Chalmers J; MacMahon S; Neal B
    J Clin Hypertens (Greenwich); 2009 Feb; 11(2):108; author reply 109-10. PubMed ID: 19222680
    [No Abstract]   [Full Text] [Related]  

  • 35. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.
    Berecek KH; Farag A; Bahtiyar G; Rothman J; McFarlane SI
    Curr Hypertens Rep; 2004 Jun; 6(3):212-4. PubMed ID: 15128474
    [No Abstract]   [Full Text] [Related]  

  • 36. [Progress on the drug therapy for diabetic microangiopathies: RA system inhibitor].
    Higashiura K; Shimamoto K
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():144-9. PubMed ID: 15999698
    [No Abstract]   [Full Text] [Related]  

  • 37. Antihypertensive therapy for the prevention of nephropathy in diabetic hypertensive patients.
    Isaacs AN; Vincent A
    J Clin Pharm Ther; 2016 Apr; 41(2):111-5. PubMed ID: 26850093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renoprotection by angiotensin-receptor blockers and ACE inhibitors in hypertension.
    Opie LH
    Lancet; 2001 Dec; 358(9296):1829-31. PubMed ID: 11741617
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular and metabolic benefits of ACE inhibition: moving beyond blood pressure reduction.
    Gerstein HC
    Diabetes Care; 2000 Jul; 23(7):882-3. PubMed ID: 10895833
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.
    Berl T; Hunsicker LG; Lewis JB; Pfeffer MA; Porush JG; Rouleau JL; Drury PL; Esmatjes E; Hricik D; Parikh CR; Raz I; Vanhille P; Wiegmann TB; Wolfe BM; Locatelli F; Goldhaber SZ; Lewis EJ;
    Ann Intern Med; 2003 Apr; 138(7):542-9. PubMed ID: 12667024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.